Peptide Blends · Exact presentation
Tesamorelin 5mg + Ipamorelin 5mg · 10mg Blend
Tesamorelin 5mg + Ipamorelin 5mg · 10mg Blend is a declared multi-component single-vial blend. Evidence for each component does not automatically establish the performance of the combination.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
Dosing & Reconstitution Guide
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL total)
The source chart summarizes “125 mcg–1 mg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL total)
| Week | Tesamorelin Dose | Ipamorelin Dose | Units (mL) |
|---|---|---|---|
| Weeks 1–2 | 250 mcg (0.25 mg) | 125 mcg (0.125 mg) | 23 units (0.23 mL) |
| Weeks 3–4 | 500 mcg (0.5 mg) | 250 mcg (0.25 mg) | 45 units (0.45 mL) |
| Weeks 5–6 | 1000 mcg (1.0 mg) | 500 mcg (0.5 mg) | 90 units (0.90 mL) |
| Weeks 7–10 | 1500 mcg (1.5 mg) | 750 mcg (0.75 mg) | 135 units (1.35 mL) |
| Weeks 11–16 | 2000 mcg (2.0 mg) | 1000 mcg (1.0 mg) | 180 units (1.80 mL) |
Reconstitution Steps
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.
Potential Benefits & Side Effects
Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.
Source trail
Scientific references and source discovery
- PeptideDosages — exact Tesamorelin 5mg + Ipamorelin 5mg · 10mg Blend entrysecondary-structure
- PubMed — literature search for Tesamorelin 5mg + Ipamorelin 5mgprimary-discovery
- ClinicalTrials.gov — study search for Tesamorelin 5mg + Ipamorelin 5mgtrial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference